NCT00248365View on ClinicalTrials.gov

Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

August 31, 2007

Conditions

Graft vs Host Disease

Interventions

BIOLOGICAL

Theralux extracorporeal photochemotherapy

Trial Locations (4)

V5Z 1L3

B.C. Cancer Research Center, Vancouver

L8N 3Z5

McMaster University Medical Center, Hamilton

K1H 8L6

Ottawa General Hospital, Ottawa

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Kiadis Pharma

INDUSTRY

NCT00248365 - Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD) | Biotech Hunter | Biotech Hunter